Skip To Main Content
Juber Pendhari on Muck Rack

Juber Pendhari

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Juber

Contact Juber, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?

|
By Aalia Khan, Rahul Purwar, Sweety Asija, Juber Pendhari
| Wiley Online Library Verified
3.3 Exorbitant cost of the therapy CAR-T cell therapy is regarded as one of the most expensive cancer treatment options available. The cost of a single dose of approved CAR-T cell therapy ranges from $300 000 to $500 000, and has remained unchanged since the first product approval.56 Unfortunately, the high cost of the therapy restricts its accessibility and applicability for individuals in the socioeconomically vulnerable class of society.
Open in Who Shared Issue with article?
See all 1 articles